Search

everythinglearnresearchcommunity

for

Search:↓

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Finasteride improves hair growth in men with androgenetic alopecia.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Finasteride and dutasteride effectively treat hair loss, but may cause side effects like sexual dysfunction and depression.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

New tests detect finasteride and dutasteride in urine quickly and easily.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Finasteride negatively affects fish reproduction and gonadal development.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.